(MS) Morgan Stanley - Ratings and Ratios
Wealth Management, Investment Management, Institutional Securities
Dividends
| Dividend Yield | 2.20% |
| Yield on Cost 5y | 7.03% |
| Yield CAGR 5y | 26.19% |
| Payout Consistency | 90.7% |
| Payout Ratio | 39.5% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 25.4% |
| Value at Risk 5%th | 38.6% |
| Relative Tail Risk | -7.65% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.06 |
| Alpha | 19.10 |
| CAGR/Max DD | 1.03 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.466 |
| Beta | 1.318 |
| Beta Downside | 1.502 |
| Drawdowns 3y | |
|---|---|
| Max DD | 29.24% |
| Mean DD | 7.97% |
| Median DD | 5.98% |
Description: MS Morgan Stanley December 01, 2025
Morgan Stanley (NYSE: MS) is a diversified financial services firm that operates across Institutional Securities, Wealth Management, and Investment Management. It delivers capital-raising, underwriting, M&A advisory, and project-finance services to governments, corporations, and high-net-worth individuals worldwide.
In the Institutional Securities segment, the bank combines equity and fixed-income sales, prime brokerage, and market-making. Recent data show that net revenue in Q3 2024 rose 5% YoY to roughly $13.5 billion, driven largely by higher trading volumes and a 12% increase in underwriting fees.
The Wealth Management arm, anchored in North America and expanding in Asia, now oversees about $2.5 trillion in client assets, with a 2024-23 net new assets inflow of $120 billion, reflecting strong demand for discretionary portfolio management amid volatile equity markets.
Investment Management provides multi-asset solutions to pension plans, sovereign wealth funds, and endowments, managing roughly $1.1 trillion in assets. A key sector driver is the ongoing shift toward ESG-focused allocations, which has lifted the firm’s alternatives AUM by 8% year-over-year.
Given the firm’s exposure to interest-rate cycles and global M&A activity, analysts should monitor the Federal Reserve policy path and cross-border deal flow as primary risk factors.
For a deeper, data-driven look at Morgan Stanley’s valuation dynamics, consider exploring the ValueRay platform’s quantitative models.
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income (16.18b TTM) > 0 and > 6% of Revenue (6% = 6.73b TTM) |
| FCFTA -0.01 (>2.0%) and ΔFCFTA 1.19pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -556.6% (prev -249.8%; Δ -306.8pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA -0.01 (>3.0%) and CFO -15.97b <= Net Income 16.18b (YES >=105%, WARN >=100%) |
| Net Debt (341.15b) to EBITDA (26.27b) ratio: 12.99 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.26 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (1.59b) change vs 12m ago -0.99% (target <= -2.0% for YES) |
| Gross Margin 56.91% (prev 53.73%; Δ 3.18pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 8.55% (prev 8.06%; Δ 0.49pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 0.44 (EBITDA TTM 26.27b / Interest Expense TTM 47.86b) >= 6 (WARN >= 3) |
Altman Z'' -2.53
| (A) -0.46 = (Total Current Assets 216.31b - Total Current Liabilities 840.30b) / Total Assets 1364.81b |
| (B) 0.08 = Retained Earnings (Balance) 112.43b / Total Assets 1364.81b |
| (C) 0.02 = EBIT TTM 21.10b / Avg Total Assets 1311.42b |
| (D) 0.08 = Book Value of Equity 106.10b / Total Liabilities 1253.76b |
| Total Rating: -2.53 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 44.99
| 1. Piotroski 3.50pt |
| 2. FCF Yield -3.11% |
| 3. FCF Margin -16.17% |
| 4. Debt/Equity 3.77 |
| 5. Debt/Ebitda 12.99 |
| 6. ROIC - WACC (= -2.00)% |
| 7. RoE 15.07% |
| 8. Rev. Trend 95.10% |
| 9. EPS Trend 50.18% |
What is the price of MS shares?
Over the past week, the price has changed by +3.08%, over one month by +6.63%, over three months by +16.89% and over the past year by +38.31%.
Is MS a buy, sell or hold?
- Strong Buy: 5
- Buy: 1
- Hold: 17
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the MS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 169.6 | -3% |
| Analysts Target Price | 169.6 | -3% |
| ValueRay Target Price | 222.4 | 27.1% |
MS Fundamental Data Overview November 29, 2025
P/E Trailing = 17.3832
P/E Forward = 16.0
P/S = 3.9519
P/B = 2.6634
P/EG = 1.3554
Beta = 1.217
Revenue TTM = 112.10b USD
EBIT TTM = 21.10b USD
EBITDA TTM = 26.27b USD
Long Term Debt = 332.20b USD (from longTermDebt, last quarter)
Short Term Debt = 82.43b USD (from shortTermDebt, last quarter)
Debt = 414.62b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 341.15b USD (from netDebt column, last quarter)
Enterprise Value = 582.41b USD (270.83b + Debt 414.62b - CCE 103.05b)
Interest Coverage Ratio = 0.44 (Ebit TTM 21.10b / Interest Expense TTM 47.86b)
FCF Yield = -3.11% (FCF TTM -18.13b / Enterprise Value 582.41b)
FCF Margin = -16.17% (FCF TTM -18.13b / Revenue TTM 112.10b)
Net Margin = 14.43% (Net Income TTM 16.18b / Revenue TTM 112.10b)
Gross Margin = 56.91% ((Revenue TTM 112.10b - Cost of Revenue TTM 48.30b) / Revenue TTM)
Gross Margin QoQ = 56.85% (prev 54.71%)
Tobins Q-Ratio = 0.43 (Enterprise Value 582.41b / Total Assets 1364.81b)
Interest Expense / Debt = 3.13% (Interest Expense 12.96b / Debt 414.62b)
Taxrate = 22.78% (1.37b / 6.03b)
NOPAT = 16.29b (EBIT 21.10b * (1 - 22.78%))
Current Ratio = 0.26 (Total Current Assets 216.31b / Total Current Liabilities 840.30b)
Debt / Equity = 3.77 (Debt 414.62b / totalStockholderEquity, last quarter 109.96b)
Debt / EBITDA = 12.99 (Net Debt 341.15b / EBITDA 26.27b)
Debt / FCF = -18.82 (negative FCF - burning cash) (Net Debt 341.15b / FCF TTM -18.13b)
Total Stockholder Equity = 107.37b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.19% (Net Income 16.18b / Total Assets 1364.81b)
RoE = 15.07% (Net Income TTM 16.18b / Total Stockholder Equity 107.37b)
RoCE = 4.80% (EBIT 21.10b / Capital Employed (Equity 107.37b + L.T.Debt 332.20b))
RoIC = 3.76% (NOPAT 16.29b / Invested Capital 433.50b)
WACC = 5.76% (E(270.83b)/V(685.46b) * Re(10.87%) + D(414.62b)/V(685.46b) * Rd(3.13%) * (1-Tc(0.23)))
Discount Rate = 10.87% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.05%
Fair Price DCF = unknown (Cash Flow -18.13b)
EPS Correlation: 50.18 | EPS CAGR: 9.24% | SUE: 4.0 | # QB: 7
Revenue Correlation: 95.10 | Revenue CAGR: 22.51% | SUE: 1.04 | # QB: 2
EPS next Quarter (2026-03-31): EPS=2.79 | Chg30d=+0.016 | Revisions Net=+7 | Analysts=11
EPS next Year (2026-12-31): EPS=10.56 | Chg30d=+0.113 | Revisions Net=+6 | Growth EPS=+6.5% | Growth Revenue=+5.3%
Additional Sources for MS Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle